Immersive Virtual Reality (IVR) Procedure (IVR-P)

April 29, 2024 updated by: Lau Siew Tiang, National University of Singapore

Enhancing Clinical Procedures Through Deliberate Practice Using Immersive Virtual Reality

A pilot randomised controlled trial to assess the nursing students' learning outcomes of the urinary catheterisation procedure by comparing the immersive virtual reality (IVR) to traditional lab sessions.

Study Overview

Detailed Description

Design: A pilot randomised controlled trial was employed to assess the learning outcomes of the urinary catheterisation procedure by comparing the immersive virtual reality (IVR) intervention to traditional lab sessions.

Eligibility: Second-year undergraduate nursing students (n = 200) enrolled into the module NUR2125 (Pathophysiology, Pharmacology and Nursing Practice II) were invited to participate in the study.

Setting: The study was conducted at a university in Singapore from January to April 2023.

Procedure: Ten lab groups of second-year undergraduate nursing students were invited to participate in the study. They received the standard blended learning activities, which included clinical lab sessions and videos on the urinary catheterisation procedure. Out of the ten groups, four groups were randomly allocated to the IVR intervention group, and another four groups were randomly assigned to the waitlist control group (traditional lab sessions).

  1. For the intervention group (IVR), the students used the IVR device for practice in class under the supervision of their tutor. They then loaned the IVR device for two weeks for home practice.
  2. For the waitlist control group (traditional lab sessions), they learned and practiced the urinary catheterisation procedure in class. Students received the additional intervention (using the IVR device for home practice) after the collection of post-test data.

Data collection: Prior to lab practice, each participant completed a demographic survey and a set of pre-test questionnaires on personality inventory, cognitive load, and representation of VR in education. Only students who voluntarily joined the programme were recruited into the study.

The participants completed the post-test questionnaires in March 2023 prior to their formative clinical assessment.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 117597
        • Alice Lee Centre for Nursing Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Year 2 Nursing students enrolled in the PPNP2 module

Exclusion Criteria:

  • Students who declined to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immersive Virtual Reality
The Participants used Immersive Virtual Reality for learning and practice urinary catheterisation procedure
Using immersive virtual reality to learn urinary catheterisation procedure
Active Comparator: Nursing clinical laboratory
The Participants used a traditional nursing clinical laboratory for face to face learning and practice urinary catheterisation procedure
Using nursing clinical laboratory sessions to learn urinary catheterisation procedure
Other Names:
  • Active Comparator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Load
Time Frame: 3 months
The Cognitive Load Scale (CLS) was adapted from Leppink et al. (2013) and analyses the level of working memory resources needed to process information. It consists of 10 items that are rated on an 11-point scale (0 = Not at all the case to 10 = Completely the case). Items 1 to 3 relate to intrinsic load, items 4 to 6 fall under extraneous load, and items 7 to 10 are associated with germane load. Responses are added to give a total score for each subscale, which ranges from 0 (lowest) to 30 or 40 (highest) in the case of the germane load subscale. Higher total scores indicate more working memory resources required to process the information load under different conditions.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical skill competency
Time Frame: 3 months
To evaluate the skills competency, the nursing students were assessed by their tutors using a competency assessment tool based on the skills checklist. Within the checklist, it determined the performance of the participants on completing the procedural steps on a 10-point scale (0-3 = Need improvement, 4-6 = Meet expectation, 7-9 = Exceed expectation), which was computed into a percentage score. Higher scores indicate a higher competency level in conducting the urinary catheterization procedure.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Siew Tiang LAU, PhD, National University of Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2023

Primary Completion (Actual)

March 27, 2023

Study Completion (Actual)

March 27, 2023

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

April 29, 2024

First Posted (Actual)

May 2, 2024

Study Record Updates

Last Update Posted (Actual)

May 2, 2024

Last Update Submitted That Met QC Criteria

April 29, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Procedure

Clinical Trials on IVR-Procedure

3
Subscribe